|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.80 EUR | -1.78% |
|
+1.41% | +39.33% |
| 07-01 | Health Care Up on AI Rotation - Health Care Roundup | DJ |
| 07-01 | Galderma Hits FDA Setback Again in Bid to Launch Botox Rival in U.S. -- Update | DJ |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 13,612 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 39.33% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 12,186 | 11,159 | 10,372 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 32.1% | -8.43% | -7.05% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 15.1x | 14.8x | 14.8x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.76x | 2.29x | 1.98x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | 7.79x | 50.55x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 3.19x | 3.04x | 2.92x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.86x | 2.49x | 2.22x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 7.3x | 6.59x | 6.2x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 8.5x | 7.59x | 7.06x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 11.1x | 9.73x | 8.85x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 9.03% | 10.3% | 11.3% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.436 | 1.489 | 1.582 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.87% | 0.9% | 0.95% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 10.97 | 11.18 | 11.22 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 13.1% | 13.3% | 14.1% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,265 | 4,479 | 4,667 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,670 | 1,693 | 1,674 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,434 | 1,470 | 1,468 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 939.7 | 948.5 | 947.3 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,426 | -2,453 | -3,240 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 165.80 | 165.80 | 165.80 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 82,100 | - | - |
| Announcement Date | 2/11/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.42x | 2.91x | 7.43x | 0.85% | 15.83B | ||
| 35.06x | 12.74x | 25.95x | 0.57% | 1,070B | ||
| 27.14x | 6.24x | 16.98x | 2.1% | 611B | ||
| 31.04x | 7.44x | 15.22x | 2.75% | 445B | ||
| 17.73x | 4.41x | 10.84x | 3.01% | 329B | ||
| 23.3x | 4.89x | 13.84x | 1.78% | 290B | ||
| 21.86x | 5.61x | 13.55x | 2.82% | 287B | ||
| 13.89x | 5.16x | 10.6x | 3.6% | 213B | ||
| 23.6x | 6.28x | 11.05x | 2.79% | 195B | ||
| -45.11x | 5.46x | 30.35x | 2.57% | 157B | ||
| Average | 16.39x | 6.11x | 15.58x | 2.28% | 361.21B | |
| Weighted average by Cap. | 24.22x | 7.88x | 18.18x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
















